CLINICAL EFFICACY OF THE DOMESTIC MUCOLYTIC DRUG ASCEIN (N-ACETYLCYSTEINE) IN THE COMPLEX TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Keywords:
chronic obstructive pulmonary disease, treatment, mucolytic therapy, N-acetylcysteineAbstract
Chronic obstructive pulmonary disease (COPD) is one of the most common pathologies of the respiratory system and is often the cause of disability and mortality of this category of patients. An unfavorable prognosis is often due to late diagnosis of COPD. Over the past decade, certain successes have been achieved in the study of pathogenesis, clinic, early diagnosis and treatment of COPD. COPD therapy includes pharmacological and non-pharmacological approaches that can significantly reduce clinical symptoms and reduce the frequency of exacerbations of the disease. Mucolytic therapy such as N-acetylcysteine, ambroxol, or carbocysteine may also be considered in patients with chronic bronchitis. Our study showed that when N-acetylcysteine was included in the complex treatment of moderate COPD in the acute stage, SpO2 levels significantly increased, shortness of breath, cough symptoms and the amount of sputum excreted decreased, which significantly improves the clinical picture and quality of life of patients.
Downloads
References
Liverko I.V. et al. Epidemiological situation of chronic obstructive pulmonary disease in the world and in Uzbekistan / I. V. Liverko, Yu. E. Fattakhova, R. A. Nalibayeva. A young scientist. 2021;40(382):47-51. URL: https://moluch.ru/archive/382/84336/.
Ovcharenko S.I., Kapustina V.A. The role of N-acetylcysteine in the complex treatment of patients with chronic obstructive pulmonary disease. Clinician.2010;1:64-68.
Chuchalin A.G. et al. Chronic obstructive pulmonary disease: federal clinical guidelines for diagnosis and treatment/ Chuchalin A.G., Avdeev S.N., Aisanov Z.R., Belevsky A.S., Leshchenko I.V., Ovcharenko S.I., Shmelev E.I. Pulmonology. 2022;32(3):356-392. https://doi.org/10.18093/0869-0189-2022-32-3-356-392.
Yamashkina A.S. Chronic obstructive pulmonary disease. student. 2020;No.11. URL: https://cyberleninka.ru/article/n/hronicheskaya-obstruktivnaya-bolezn-legkih-3.
Kazzola M., Calcita L., Page S. et al. The effect of N-aetilhisteine on genetic bronchitis or other activity: meta-analysis. Euro. Respir. Editorial 2015; 24 (137): 451-461. DOI: 10.1183/16000617.00002215.
Matsunaga K., Oishi K., Miravitles M., Anzueto A. It's Time To Revise The Algorithm Of COLD Treatment. June 2019, 14:2229-2234.
Pool P., Black P.N., Kats K.J. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. The Cochrane database system. Revision 2012; (8): CD001287. DOI: 10.1002/14651858.CD001287. pub4.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles published in this journal are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). Under this license:
- Share: Copy and redistribute the material in any medium or format
- Adapt: Remix, transform, and build upon the material for any purpose, including commercially
Attribution required: You must give appropriate credit, provide a link to the license, and indicate if changes were made.
License URL: https://creativecommons.org/licenses/by/4.0/
Authors retain copyright of their work while granting the journal first publication rights.
